Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Mar 15, 2019 (8 years ago)

Repairwear Laser Focus Line Smoothing Cream Broad Spectrum SPF 15

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Defective container: Ineffective seal between the cap and jar of the affected product.

Cause type: Packaging defect

Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination. All packaging defect recalls.

What was recalled

Repairwear Laser Focus Line Smoothing Cream Broad Spectrum SPF 15, packaged in a light green folding carton containing a 50 mL silver jar with a silver cap, Clinique Laboratories, Dist. New York, NY 10022

Recalling firm
Estee Lauder Inc
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1132-2019 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Estee Lauder Inc

All 2019 recalls
Class III · Low risk

ESTEE LAUDER DayWear Sheer Tint Release

Failed Stability Specifications: The active sunscreen ingredient, avobenzone 3%, may not be stable over the shelf life, the sunscreen effectiveness may be less than labeled.

Terminated Stability / shelf life Estee Lauder Inc NDC 11559-008-01 D-151-2013

Other packaging defect recalls from 2019

All packaging defect recalls
Class III · Low risk

VCF Vaginal Contraceptive Foam

Defective Delivery System: canister unit exhibiting propellant leakage or loss, rendering the product and canister unusable

Terminated Packaging defect Apothecus Pharmaceutical Corp. NDC 52925-312-14 D-0623-2020
Class III · Low risk

Clobetasol Propionate Foam

Defective delivery system; product is not foaming or is coming out as liquid.

Terminated Packaging defect Glenmark Pharmaceuticals Inc., USA NDC 68462-625-27 D-0619-2020
Class III · Low risk

Clobetasol Propionate Foam

Defective delivery system; product is not foaming or is coming out as liquid.

Terminated Packaging defect Glenmark Pharmaceuticals Inc., USA NDC 68462-608-27 D-0618-2020
Class II · Moderate risk

Estradiol Vaginal Inserts USP

Defective Delivery System: complaints for difficulty in pushing the plunger of the applicator.

Terminated Packaging defect Glenmark Pharmaceuticals Inc., USA NDC 68462-711-71 D-0156-2020